Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-12-04 7:08 pm Purchase | 13D | Senti Biosciences Inc. SNTI | New Enterprise Associates 15 L.P. | 442,615 9.600% | 442,615 (New Position) | View |
| 2023-02-14 12:38 pm Purchase | 13G | Senti Biosciences Inc. SNTI | PRICE T ROWE ASSOCIATES INC | 3,554,017 8.100% | 3,554,017 (New Position) | View |
| 2023-02-14 11:52 am Unchanged | 13G | Senti Biosciences Inc. SNTI | Sculptor Capital LP | 0 0.000% | 0 (Unchanged) | View |
| 2023-02-13 5:14 pm Purchase | 13G | Senti Biosciences Inc. SNTI | BAYER HEALTHCARE LLC | 5,878,488 13.400% | 5,878,488 (New Position) | View |
| 2023-02-10 4:09 pm Unchanged | 13G | Senti Biosciences Inc. SNTI | Woodline Partners LP | 0 0.000% | 0 (Unchanged) | View |
| 2023-02-09 4:06 pm Purchase | 13G | Senti Biosciences Inc. SNTI | MORGAN STANLEY MS | 249,858 0.600% | 249,858 (New Position) | View |
| 2023-02-08 4:35 pm Purchase | 13G | Senti Biosciences Inc. SNTI | Lonsdale Joe | 2,537,558 5.800% | 2,537,558 (New Position) | View |
| 2022-07-15 5:24 pm Purchase | 13D | Senti Biosciences Inc. SNTI | New Enterprise Associates 15 L.P. | 4,426,151 10.100% | 4,426,151 (New Position) | View |
| 2022-04-05 11:21 am Sale | 13G | Senti Biosciences Inc. SNTI | JPMORGAN CHASE & CO JPM | 551,978 2.300% | -773,022 (-58.34%) | View |
| 2022-02-14 5:07 pm Sale | 13G | Senti Biosciences Inc. SNTI | Redmile Group LLC | 0 0.000% | -2,012,900 (Position Closed) | View |
| 2022-02-11 3:08 pm Purchase | 13G | Senti Biosciences Inc. SNTI | Sculptor Capital LP | 1,540,293 6.490% | 2,981 (+0.19%) | View |
| 2022-02-11 07:26 am Purchase | 13G | Senti Biosciences Inc. SNTI | Woodline Partners LP | 2,000,000 8.400% | 2,000,000 (New Position) | View |
| 2022-02-10 11:51 am Sale | 13G | Senti Biosciences Inc. SNTI | MORGAN STANLEY MS | 2,890,650 12.200% | -110,887 (-3.69%) | View |
| 2022-02-10 11:13 am Purchase | 13G | Senti Biosciences Inc. SNTI | ARK Investment Management LLC | 2,371,891 10.000% | 9,214 (+0.39%) | View |
| 2022-02-09 2:31 pm Sale | 13G | Senti Biosciences Inc. SNTI | ARK Investment Management LLC | 2,362,677 9.960% | -15,026 (-0.63%) | View |
| 2022-02-03 1:31 pm Purchase | 13G | Senti Biosciences Inc. SNTI | JPMORGAN CHASE & CO JPM | 1,325,000 5.500% | 1,325,000 (New Position) | View |
| 2021-12-29 5:02 pm Purchase | 13G | Senti Biosciences Inc. SNTI | Sculptor Capital LP | 1,537,312 6.480% | 1,537,312 (New Position) | View |
| 2021-09-10 2:47 pm Purchase | 13G | Senti Biosciences Inc. SNTI | ARK Investment Management LLC | 2,377,703 10.030% | 2,377,703 (New Position) | View |
| 2021-06-10 4:49 pm Purchase | 13G | Senti Biosciences Inc. SNTI | MORGAN STANLEY MS | 3,001,537 14.500% | 3,001,537 (New Position) | View |
| 2021-06-10 12:44 pm Purchase | 13G | Senti Biosciences Inc. SNTI | PRICE T ROWE ASSOCIATES INC | 3,000,000 12.600% | 3,000,000 (New Position) | View |